Limited RT efficacy may be caused by tumour microenvironement hypoxia, which is definitely anticipated in large RPS and results in decreased DNA damage and by acquired immune tolerance due to amplified PD-L1 expression [77]. This evidence concerns the gene CD274 and neoplasm.